Instruments for measuring body image in breast cancer patients: a systematic review of measurement properties.

Qual Life ResSep 6, 2026 (epub)
Clinical ResearchOncology (Medical)Plastic SurgeryOpen access

Yuanyuan Pang, Qifan Ding, Ru Feng et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated the psychometric properties of patient-reported outcome measures (PROMs) for body image in breast cancer patients. Thirty-eight articles assessing fifteen PROMs were included. The BIS is recommended as a temporary screening tool, while the BIRS is tentatively advised for specific postoperative assessments. However, further validation studies are necessary.

Key findings

  • Twelve instruments show potential application value but require further research.
  • The BAS-BC, PSPP, and ASI-R do not meet COSMIN thresholds for full recommendation.
  • Structural validity, internal consistency, and hypothesis testing were most frequently evaluated.

Why it matters

Understanding body image is crucial for breast cancer patients, as it can significantly impact their quality of life. Validated tools can help clinicians assess and address these concerns effectively.

Source

PubMed · PMID 42701946Free full text on PubMed Central

Published in Qual Life Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Clinical ResearchOncology (Medical)

Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.

This phase 3 randomized clinical trial evaluated the efficacy and safety of osimertinib combined with chemotherapy versus osimertinib alone in 294 patients with advanced non-small cell lung cancer (NSCLC) harboring…

JAMASep 8, 2026Open accessRead summary
Clinical ResearchHematology

Azacitidine-Venetoclax or Induction Chemotherapy for Acute Myeloid Leukemia.

This phase 2 randomized trial compared azacitidine plus venetoclax to induction chemotherapy in 172 previously untreated adults with acute myeloid leukemia (AML) eligible for induction.

N Engl J MedSep 3, 2026Read summary
Clinical ResearchPsychiatry

The efficacy of modified psychodynamic psychotherapy for patients with schizophrenia-spectrum disorders in Germany: a prospective, single-centre, assessor-blinded, parallel-group, randomised controlled trial.

This randomized controlled trial evaluated the efficacy of Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S) combined with treatment as usual (TAU) in 130 outpatients with schizophrenia-spectrum disorders…

Lancet PsychiatrySep 10, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.